Etalocib

• Description:

  Etalocib is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  544.6

• Molecular Formula:

  C33H33FO6

• Notes:

  Research use only, not for human use.

• Receptor:

  Apoptosis|LTB4

• CAS Number:

  161172-51-6